These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8674870)

  • 21. Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.
    Osteoporos Int; 1997; 7 Suppl 3():1-222. PubMed ID: 9565455
    [No Abstract]   [Full Text] [Related]  

  • 22. [A nationwide retrospective analysis on chronic diabetic complications and related macrovascular diseases of in-patients with diabetes during 1991-2000].
    ;
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):447-51. PubMed ID: 12905762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.
    Tang L; Li L; Yang J; Zeng C
    Braz J Med Biol Res; 2017 Aug; 50(10):e6511. PubMed ID: 28832766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2nd Osaka International Symposium on Gastroenterology. Osaka, Japan, November 22-23, 1993. Abstracts.
    Dig Dis Sci; 1994 Apr; 39(4):897-927. PubMed ID: 7908625
    [No Abstract]   [Full Text] [Related]  

  • 25. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications.
    Armstrong AW; Guérin A; Sundaram M; Wu EQ; Faust ES; Ionescu-Ittu R; Mulani P
    J Am Acad Dermatol; 2015 Jun; 72(6):968-77.e2. PubMed ID: 25791800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between mannose-binding lectin 2 gene and protein kinase C-beta 1 gene polymorphisms and type 2 diabetic macrovascular complications in northern Chinese Han population].
    Zhang NN; Yao L; Zhuang MQ; Wang GC; Chen TT; Yang YJ; Zhang J; Lv M; Jin L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):709-14. PubMed ID: 23225056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Japanese Environmental Mutagen Society. Abstracts of papers presented at the 6th annual meeting, November 16th--17th, 1977, Suita-shi, Osaka (Japan).
    Mutat Res; 1978 Oct; 54(2):233-63. PubMed ID: 30896
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulfonylurea drugs: basic and clinical considerations. A symposium presented before the 13th International Diabetes Federation Congress. Sydney, Australia, 20 November 1988. Proceedings.
    Diabetes Care; 1990 Aug; 13 Suppl 3():1-58. PubMed ID: 2209338
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings of the International Taurine Symposium '95. Osaka, Japan, June 1995.
    Adv Exp Med Biol; 1996; 403():3-658. PubMed ID: 9054209
    [No Abstract]   [Full Text] [Related]  

  • 30. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
    Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
    Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
    Grauslund J; Rasmussen LM; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrovascular disease in diabetes mellitus. Pathogenesis and prevention. International workshop, Garmisch-Grainau, October 1984.
    Horm Metab Res Suppl; 1985; 15():1-122. PubMed ID: 3865875
    [No Abstract]   [Full Text] [Related]  

  • 33. US assessment of medial arterial calcification: a sensitive marker of diabetes-related microvascular and macrovascular complications.
    Liu KH; Chu WC; Kong AP; Choi Ko GT; Ma RC; Chan JW; Chow LT; Rasalkar DD; So WY; Tse LF; Corcoran HS; Ozaki R; Ahuja AT; Chan JC
    Radiology; 2012 Oct; 265(1):294-302. PubMed ID: 22843765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of macrovascular complications in diabetics of WAH, District Rawalpindi.
    Hashim R; Khan FA; Khan DA; Shaukat A
    J Pak Med Assoc; 1999 Jan; 49(1):8-11. PubMed ID: 10463008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrovascular disease in diabetes: is the mouse a suitable model?
    Müller OJ; Katus HA; Backs J
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):194-6. PubMed ID: 22402944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings of the 4th International Symposium on Radioautography, satellite symposium of the 25th annual meeting of the Clinical Electron Microscopy Society of Japan. Matsumoto, Japan, September 28-October 2, 1993.
    Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):1-212. PubMed ID: 7773123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Assessment of macrovascular complications in type 2 diabetes mellitus].
    Rev Invest Clin; 2000; 52(3):354-62. PubMed ID: 10953622
    [No Abstract]   [Full Text] [Related]  

  • 38. Macrovascular complications and their associated risk factors in type 2 diabetic patients in Sana'a city, Yemen.
    Al-Khawlani A; Atef ZA; Al-Ansi A
    East Mediterr Health J; 2010 Aug; 16(8):851-8. PubMed ID: 21469567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of the 8th International Symposium on SHR and Related Studies. Osaka, Japan, 18-20 October 1994.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S1-379. PubMed ID: 9072311
    [No Abstract]   [Full Text] [Related]  

  • 40. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.